Molecular Therapy-methods & Clinical Development

Journal Title：Molecular Therapy-methods & Clinical Development

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella.

Topics of particular interest within the journal's scope include:

Gene vector engineering and production,

Methods for targeted genome editing and engineering,

Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells,

Methods for gene and cell vector delivery,

Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine,

Analysis of gene and cell vector biodistribution and tracking,

Pharmacology/toxicology studies of new and next-generation vectors,

Methods for cell isolation, engineering, culture, expansion, and transplantation,

Cell processing, storage, and banking for therapeutic application,

Preclinical and QC/QA assay development,

Translational and clinical scale-up and Good Manufacturing procedures and process development,

Clinical protocol development,

Computational and bioinformatic methods for analysis, modeling, or visualization of biological data,

Negotiating the regulatory approval process and obtaining such approval for clinical trials.

《分子疗法—方法与临床发展》的目标是在《分子疗法》成功的基础上，发表重要的同行评审方法和程序，以及分子疗法领域广泛领域的转化进展。

该期刊范围内特别感兴趣的主题包括：

基因载体工程和生产，

靶向基因组编辑和工程方法，

细胞重编程和多能细胞定向分化的方法和技术开发，

基因和细胞载体递送方法，

用于基因和细胞治疗以及再生医学应用的生物材料和纳米颗粒的开发，

基因和细胞载体生物分布和追踪分析，

新一代和下一代载体的药理学/毒理学研究，

细胞方法分离、工程、培养、扩增和移植，

用于治疗应用的细胞处理、储存和储存，

临床前和 QC/QA 检测开发，

转化和临床扩大以及良好生产程序和工艺开发，

临床方案开发，

用于分析、建模或可视化生物数据的计算和生物信息学方法，

协商监管审批流程并获得临床试验批准。

Molecular Therapy-methods & Clinical Development创刊于2014年，由Cell Press出版商出版，收稿方向涵盖Biochemistry, Genetics and Molecular Biology - Molecular Biology全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度12 Weeks，影响因子指数4.533，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。